Concerns about the consequences of cancer predisposition and relationships with quality of life in young adults with Li-Fraumeni syndrome
Li-Fraumeni syndrome (LFS) is an inherited condition associated with high multi-organ cancer risks from birth. Young adults (YAs; 18-39 years) with LFS experience psychosocial challenges that may negatively affect health-related quality of life (HRQOL). This study aimed to describe a specific psychosocial challenge, concerns about the consequences of LFS (CC-LFS), and investigate relationships among CC-LFS and HRQOL among YAs. An online survey assessed CC-LFS and HRQOL among YAs with LFS enrolled in a National Cancer Institute study. Regression analyses examined relationships between CC-LFS and HRQOL scores, adjusted for age, cancer, and history of mental health challenges. Of 37 total respondents (78% female; M<sub>age</sub> = 31 years), 51% had a cancer history. Many reported past mental health challenges, including emotional problems (70%), depression/anxiety disorders (68%), and suicidal ideation (43%). Mean scores for mental (M = 65.8), physical (M = 67.5), and general (M = 63.9) HRQOL were lower than in the general population. Higher CC-LFS scores (M = 31/50, SD = 7.2) were associated with lower scores for each HRQOL domain. Adjusting for covariates, higher CC-LFS scores were associated with lower physical HRQOL (β = -0.491, 95% CI -0.76, -0.22, p < 0.001) and general HRQOL (β = -0.466, 95% CI -0.77, -0.16, p = 0.004), but not mental HRQOL (p = 0.102). CC-LFS accounted for significant proportions of unique variance in general (R<sup>2</sup><sub>adj</sub> = 17.7%, p = 0.004) and physical HRQOL (R<sup>2</sup><sub>adj</sub> = 20.4%, p < 0.001). Findings suggest YAs with LFS may experience substantial concerns, mental health challenges, and diminished HRQOL. Concerns about LFS consequences appear to be a psychosocial risk factor that clinicians and researchers might address through targeted interventions to improve YAs' psychosocial health.
Authors
- William M. P. Klein (ORCID: https://orcid.org/0000-0002-8847-8193)
- Richard P. Moser (ORCID: https://orcid.org/0000-0001-6884-0653)
- Allison Werner‐Lin (ORCID: https://orcid.org/0000-0003-3133-820X)
- Catherine Wilsnack (ORCID: https://orcid.org/0000-0001-5427-1015)
- Alix G. Sleight (ORCID: https://orcid.org/0000-0001-5317-060X)
- Payal P. Khincha (ORCID: https://orcid.org/0000-0003-2473-7800)
- Chloe O. Huelsnitz (ORCID: https://orcid.org/0000-0001-8112-5005)
- Patrick Boyd (ORCID: https://orcid.org/0000-0001-9950-2745)
- Paul K. J. Han (ORCID: https://orcid.org/0000-0003-0165-1940)
- Camella J. Rising (ORCID: https://orcid.org/0000-0002-4099-528X)
- Sadie P. Hutson (ORCID: https://orcid.org/0000-0003-3646-9946)
- Rowan Forbes Shepherd (ORCID: https://orcid.org/0000-0003-4510-0542)
Institutions
- University of Southern California (US)
- The University of Texas MD Anderson Cancer Center (US)
- City of Hope (US)
- National Cancer Institute (US)
- Cancer Genetics (United States) (US)
- Division of Cancer Epidemiology and Genetics
- University of Pennsylvania (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- European Journal of Human Genetics
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1038/s41431-025-01984-w
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health